MA28740B1 - Methodes de traitement d'infections endobronchiques - Google Patents
Methodes de traitement d'infections endobronchiquesInfo
- Publication number
- MA28740B1 MA28740B1 MA29618A MA29618A MA28740B1 MA 28740 B1 MA28740 B1 MA 28740B1 MA 29618 A MA29618 A MA 29618A MA 29618 A MA29618 A MA 29618A MA 28740 B1 MA28740 B1 MA 28740B1
- Authority
- MA
- Morocco
- Prior art keywords
- treating
- methods
- endobronic
- infections
- patient
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 239000000443 aerosol Substances 0.000 abstract 1
- 229940126574 aminoglycoside antibiotic Drugs 0.000 abstract 1
- 239000002647 aminoglycoside antibiotic agent Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58084804P | 2004-06-18 | 2004-06-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA28740B1 true MA28740B1 (fr) | 2007-07-02 |
Family
ID=35782127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA29618A MA28740B1 (fr) | 2004-06-18 | 2007-01-17 | Methodes de traitement d'infections endobronchiques |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US20080214481A1 (https=) |
| EP (1) | EP1765288B1 (https=) |
| JP (3) | JP2008503500A (https=) |
| KR (2) | KR20120131245A (https=) |
| CN (1) | CN101014320B (https=) |
| AU (1) | AU2005258078B2 (https=) |
| BR (1) | BRPI0512146A (https=) |
| CA (1) | CA2570976C (https=) |
| DK (1) | DK1765288T3 (https=) |
| EC (1) | ECSP077182A (https=) |
| ES (1) | ES2399279T3 (https=) |
| HR (1) | HRP20130076T1 (https=) |
| IL (1) | IL179873A (https=) |
| MA (1) | MA28740B1 (https=) |
| MX (1) | MXPA06014567A (https=) |
| NO (1) | NO338799B1 (https=) |
| NZ (1) | NZ552047A (https=) |
| PL (1) | PL1765288T3 (https=) |
| PT (1) | PT1765288E (https=) |
| RU (1) | RU2389477C2 (https=) |
| SG (1) | SG153833A1 (https=) |
| SI (1) | SI1765288T1 (https=) |
| TN (1) | TNSN06420A1 (https=) |
| WO (1) | WO2006002178A1 (https=) |
| ZA (1) | ZA200700420B (https=) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005514393A (ja) * | 2001-12-19 | 2005-05-19 | ネクター セラピューティクス | アミノグリコシドの肺への供給 |
| US7381184B2 (en) | 2002-11-05 | 2008-06-03 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
| USD902408S1 (en) | 2003-11-05 | 2020-11-17 | Abbott Diabetes Care Inc. | Analyte sensor control unit |
| US7883464B2 (en) | 2005-09-30 | 2011-02-08 | Abbott Diabetes Care Inc. | Integrated transmitter unit and sensor introducer mechanism and methods of use |
| US7697967B2 (en) | 2005-12-28 | 2010-04-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
| US9788771B2 (en) | 2006-10-23 | 2017-10-17 | Abbott Diabetes Care Inc. | Variable speed sensor insertion devices and methods of use |
| US10226207B2 (en) | 2004-12-29 | 2019-03-12 | Abbott Diabetes Care Inc. | Sensor inserter having introducer |
| US9398882B2 (en) | 2005-09-30 | 2016-07-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor and data processing device |
| US8029441B2 (en) | 2006-02-28 | 2011-10-04 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
| US8333714B2 (en) | 2006-09-10 | 2012-12-18 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
| US8512243B2 (en) | 2005-09-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
| US9259175B2 (en) | 2006-10-23 | 2016-02-16 | Abbott Diabetes Care, Inc. | Flexible patch for fluid delivery and monitoring body analytes |
| US9521968B2 (en) | 2005-09-30 | 2016-12-20 | Abbott Diabetes Care Inc. | Analyte sensor retention mechanism and methods of use |
| US11298058B2 (en) | 2005-12-28 | 2022-04-12 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
| US20100093650A1 (en) * | 2006-10-11 | 2010-04-15 | Laboratories Smb S.A. | Pharmaceutical Anit-Infective Composition for Inhalation |
| EP1938822A1 (en) * | 2006-12-21 | 2008-07-02 | Novartis AG | Combination therapy for the treatment of airways disease |
| WO2009140587A1 (en) * | 2008-05-15 | 2009-11-19 | Novartis Ag | Pulmonary delivery of a fluoroquinolone |
| US20100198034A1 (en) | 2009-02-03 | 2010-08-05 | Abbott Diabetes Care Inc. | Compact On-Body Physiological Monitoring Devices and Methods Thereof |
| MX337126B (es) * | 2009-05-29 | 2016-02-12 | Pearl Therapeutics Inc | Administracion respiratoria de agentes activos. |
| US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
| EP2473963A4 (en) | 2009-08-31 | 2014-01-08 | Abbott Diabetes Care Inc | MEDICAL DEVICES AND METHOD |
| UA107095C2 (uk) * | 2009-12-14 | 2014-11-25 | Антибіотичні мікрочастинки для інгаляції | |
| DK3622883T3 (da) | 2010-03-24 | 2021-07-19 | Abbott Diabetes Care Inc | Indførerer til medicinsk indretning og fremgangsmåder til at indføre og anvende medicinske indretninger |
| US11064921B2 (en) | 2010-06-29 | 2021-07-20 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
| US9572774B2 (en) | 2011-05-19 | 2017-02-21 | Savara Inc. | Dry powder vancomycin compositions and associated methods |
| US8826904B2 (en) | 2011-07-12 | 2014-09-09 | Cardeas Pharma Corporation | Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis |
| CN103702663A (zh) | 2011-07-12 | 2014-04-02 | 卡迪斯制药公司 | 治疗呼吸机相关肺炎(vap)和呼吸机相关气管(vat)支气管炎的阿米卡星和磷霉素组合的制剂以及方法和系统 |
| FI3300658T3 (fi) | 2011-12-11 | 2024-03-01 | Abbott Diabetes Care Inc | Analyyttianturimenetelmiä |
| WO2014055456A1 (en) * | 2012-10-07 | 2014-04-10 | Abbott Diabetes Care Inc. | Medical device insertion indicators |
| CN102949379B (zh) * | 2012-11-14 | 2014-11-05 | 中山大学 | 硫酸奈替米星吸入粉雾剂及其制备方法 |
| KR102391332B1 (ko) | 2013-03-15 | 2022-04-26 | 펄 테라퓨틱스 인코포레이티드 | 미립자 결정질 재료를 컨디셔닝하는 방법 및 시스템 |
| AU2016260547B2 (en) | 2015-05-14 | 2020-09-03 | Abbott Diabetes Care Inc. | Compact medical device inserters and related systems and methods |
| US10213139B2 (en) | 2015-05-14 | 2019-02-26 | Abbott Diabetes Care Inc. | Systems, devices, and methods for assembling an applicator and sensor control device |
| CA3050721A1 (en) | 2017-01-23 | 2018-07-26 | Abbott Diabetes Care Inc. | Systems, devices and methods for analyte sensor insertion |
| CN113195022A (zh) | 2018-12-21 | 2021-07-30 | 雅培糖尿病护理公司 | 用于分析物传感器插入的系统、装置和方法 |
| WO2020163416A1 (en) * | 2019-02-05 | 2020-08-13 | Mylan Inc | Devices and methods for tobramycin inhalation treatment |
| USD1002852S1 (en) | 2019-06-06 | 2023-10-24 | Abbott Diabetes Care Inc. | Analyte sensor device |
| CA3188510A1 (en) | 2020-08-31 | 2022-03-03 | Vivek S. RAO | Systems, devices, and methods for analyte sensor insertion |
| US12569168B2 (en) | 2020-09-15 | 2026-03-10 | Abbott Diabetes Care Inc. | Systems, devices, and methods for analyte monitoring |
| USD999913S1 (en) | 2020-12-21 | 2023-09-26 | Abbott Diabetes Care Inc | Analyte sensor inserter |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5A (en) * | 1836-08-10 | Thomas Blanchard | Machine for mortising solid wooden shells of ships' tackle-blocks | |
| FR2224175B1 (https=) | 1973-04-04 | 1978-04-14 | Isf Spa | |
| US4069819A (en) | 1973-04-13 | 1978-01-24 | Societa Farmaceutici S.P.A. | Inhalation device |
| IT1017153B (it) | 1974-07-15 | 1977-07-20 | Isf Spa | Apparecchio per inalazioni |
| SE438261B (sv) | 1981-07-08 | 1985-04-15 | Draco Ab | Anvendning i dosinhalator av ett perforerat membran |
| GB8314308D0 (en) | 1983-05-24 | 1983-06-29 | Matburn Holdings Ltd | Medical administration devices |
| SU1335297A1 (ru) * | 1984-06-15 | 1987-09-07 | Донецкий медицинский институт им.М.Горького | Способ лечени больных хроническими заболевани ми легких |
| US4805811A (en) | 1985-03-29 | 1989-02-21 | Aktiebolaget Draco | Dosage device |
| SE448277B (sv) | 1985-04-12 | 1987-02-09 | Draco Ab | Indikeringsanordning vid en doseringsanordning for lekemedel |
| IT1228459B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore con svuotamento regolare e completo della capsula. |
| GB8909891D0 (en) | 1989-04-28 | 1989-06-14 | Riker Laboratories Inc | Device |
| IT1243344B (it) | 1990-07-16 | 1994-06-10 | Promo Pack Sa | Inalatore plurimonodose per medicamenti in polvere |
| WO1993000951A1 (en) | 1991-07-02 | 1993-01-21 | Inhale, Inc. | Method and device for delivering aerosolized medicaments |
| US5785049A (en) | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
| IS1736B (is) | 1993-10-01 | 1999-12-30 | Astra Ab | Aðferð og tæki sem stuðla að aukinni samloðun agna |
| US5388572A (en) | 1993-10-26 | 1995-02-14 | Tenax Corporation (A Connecticut Corp.) | Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same |
| ES2245780T3 (es) | 1994-05-18 | 2006-01-16 | Nektar Therapeutics | Metodos y composiciones para la formulacion de interferones como un polvo seco. |
| CZ289029B6 (cs) | 1994-09-21 | 2001-10-17 | Inhale Therapeutic Systems | Způsob aerosolizace práąku, zejména práąkového léku a zařízení k provádění tohoto způsobu |
| US5522385A (en) | 1994-09-27 | 1996-06-04 | Aradigm Corporation | Dynamic particle size control for aerosolized drug delivery |
| US5508269A (en) * | 1994-10-19 | 1996-04-16 | Pathogenesis Corporation | Aminoglycoside formulation for aerosolization |
| ES2237767T3 (es) | 1995-04-14 | 2005-08-01 | Nektar Therapeutics | Composiciones farmaceuticas en polvo que tienen una dispersabilidad mejorada. |
| US5826633A (en) | 1996-04-26 | 1998-10-27 | Inhale Therapeutic Systems | Powder filling systems, apparatus and methods |
| DE29923847U1 (de) * | 1998-05-27 | 2001-04-12 | Euroceltique S.A., Luxemburg/Luxembourg | Präparate zur Anwendung von entzündungshemmenden, insbesondere antiseptischen Wirkstoffen und/oder die Wundheilung fördernden Wirkstoffen in den unteren Atemwegen |
| PL348812A1 (en) * | 1998-12-17 | 2002-06-17 | Pathogenesis Corp | Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic |
| AU763041B2 (en) | 1999-08-25 | 2003-07-10 | Alkermes, Inc. | Modulation of release from dry powder formulations |
| US6586008B1 (en) | 1999-08-25 | 2003-07-01 | Advanced Inhalation Research, Inc. | Use of simple amino acids to form porous particles during spray drying |
| US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| ES2525087T5 (es) | 2000-05-10 | 2018-06-28 | Novartis Ag | Polvos basados en fosfolípidos para administración de fármacos |
| US6613308B2 (en) | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
| PT1320355E (pt) | 2001-05-18 | 2006-08-31 | Chiron Corp | Sistema para administracao de uma formulacao de tobramicina |
| DE10131917A1 (de) | 2001-07-02 | 2003-01-23 | Infineon Technologies Ag | Verfahren zur Erzeugung einer stufenförmigen Struktur auf einem Substrat |
| EP1443996B1 (en) | 2001-11-14 | 2011-05-18 | Novartis AG | Aerosolization apparatus comprising connectable body and endpiece |
| US20030094173A1 (en) | 2001-11-14 | 2003-05-22 | Inhale Therapeutic Systems, Inc. | Aerosolization device with improved endpiece connection |
| JP2005514393A (ja) | 2001-12-19 | 2005-05-19 | ネクター セラピューティクス | アミノグリコシドの肺への供給 |
| AU2002351271A1 (en) | 2001-12-21 | 2003-07-24 | Nektar Therapeutics | Capsule package with moisture barrier |
| EP1501479A1 (en) | 2002-05-07 | 2005-02-02 | Nektar Therapeutics | Capsules for dry powder inhalers and methods of making and using same |
| CN1493297A (zh) * | 2003-09-13 | 2004-05-05 | 南昌弘益科技有限公司 | 妥布霉素吸入粉雾剂及其制备方法 |
-
2005
- 2005-06-20 MX MXPA06014567A patent/MXPA06014567A/es active IP Right Grant
- 2005-06-20 SI SI200531661T patent/SI1765288T1/sl unknown
- 2005-06-20 RU RU2007101906/14A patent/RU2389477C2/ru active
- 2005-06-20 PT PT57660649T patent/PT1765288E/pt unknown
- 2005-06-20 ES ES05766064T patent/ES2399279T3/es not_active Expired - Lifetime
- 2005-06-20 CA CA2570976A patent/CA2570976C/en not_active Expired - Lifetime
- 2005-06-20 BR BRPI0512146-9A patent/BRPI0512146A/pt not_active Application Discontinuation
- 2005-06-20 HR HRP20130076TT patent/HRP20130076T1/hr unknown
- 2005-06-20 WO PCT/US2005/021952 patent/WO2006002178A1/en not_active Ceased
- 2005-06-20 CN CN2005800201762A patent/CN101014320B/zh not_active Expired - Lifetime
- 2005-06-20 US US11/570,584 patent/US20080214481A1/en not_active Abandoned
- 2005-06-20 SG SG200904155-9A patent/SG153833A1/en unknown
- 2005-06-20 KR KR1020127029971A patent/KR20120131245A/ko not_active Ceased
- 2005-06-20 KR KR1020067026608A patent/KR20070026604A/ko not_active Ceased
- 2005-06-20 EP EP05766064A patent/EP1765288B1/en not_active Expired - Lifetime
- 2005-06-20 DK DK05766064.9T patent/DK1765288T3/da active
- 2005-06-20 JP JP2007516838A patent/JP2008503500A/ja active Pending
- 2005-06-20 PL PL05766064T patent/PL1765288T3/pl unknown
- 2005-06-20 NZ NZ552047A patent/NZ552047A/xx not_active IP Right Cessation
- 2005-06-20 AU AU2005258078A patent/AU2005258078B2/en not_active Expired
-
2006
- 2006-12-06 IL IL179873A patent/IL179873A/en active IP Right Grant
- 2006-12-18 TN TNP2006000420A patent/TNSN06420A1/en unknown
-
2007
- 2007-01-15 NO NO20070253A patent/NO338799B1/no unknown
- 2007-01-15 ZA ZA200700420A patent/ZA200700420B/xx unknown
- 2007-01-17 MA MA29618A patent/MA28740B1/fr unknown
- 2007-01-18 EC EC2007007182A patent/ECSP077182A/es unknown
-
2011
- 2011-01-04 US US12/984,110 patent/US20110097412A1/en not_active Abandoned
-
2012
- 2012-02-22 JP JP2012036405A patent/JP2012107047A/ja active Pending
- 2012-02-24 US US13/404,359 patent/US8664187B2/en not_active Expired - Fee Related
- 2012-12-27 JP JP2012284937A patent/JP2013056947A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA28740B1 (fr) | Methodes de traitement d'infections endobronchiques | |
| WO2001092288A3 (en) | Cobalamin compounds useful as antibiotic agents and as imaging agents | |
| SG170119A1 (en) | Nutritional composition comprising indigestible oligosaccharides | |
| EP2248519A3 (en) | Non-mucoadhesive film dosage forms | |
| BRPI0414000B8 (pt) | composição farmacêutica sólida oral de liberação prolongada contendo tacrolimus na forma de uma dispersão sólida, forma de dosagem, e, uso da composição farmacêutica | |
| NO20076219L (no) | Farmasoytisk formulering med apomorfin for bukkal administrering | |
| FR2700117B1 (fr) | Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens. | |
| BRPI0408655A (pt) | formulações compreendendo um agente ativo e cacau em pó e a sua utilização | |
| EP1819227A4 (en) | PHARMACEUTICAL FORMULATIONS OF DECITABIN | |
| MY145647A (en) | (4-hydroxy-2-oxo-3h-benzothiazol-7-yl)ethylamine derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy (for example in the treatment of respiratory disease states) | |
| DE59813162D1 (de) | Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen | |
| MA27059A1 (fr) | Azithromycine en dose unique | |
| GB2446341A (en) | Method and system for transdermal drug delivery | |
| WO2006072940A3 (en) | Controlled long acting release pharmaceutical preparation for use in the oral cavity | |
| MA26788A1 (fr) | COMPOSITIONS PHARMACEUTIQUES DESTINÉES à L'ADMINISTRATION PAR VOIE ORALE DE PHLOROGLUCINOL ET LEUR PRÉPARATION | |
| BR0011845A (pt) | Complexo farmacêutico | |
| WO2005056520A8 (en) | Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy | |
| MD2211F1 (en) | Remedy for treatment of parodontium affections | |
| HUP0301408A2 (hu) | Szulodexid alkalmazása diabetikus vesebetegség kezelésére szolgáló orális gyógyszerkészítmény előállítására | |
| TNSN00211A1 (fr) | Derives d'hygromycine a nouveaux, compositions les contenant et leur utilisation | |
| BR0112035A (pt) | peptìdeos antimicrobianos de novispirin | |
| EA200400691A1 (ru) | Получение чистых стереоизомеров трицикло[5,2,1,02,6]дец-9-ил-ксантогената и содержащие их лекарственные средства | |
| MA29813B1 (fr) | Combinaisons pharmaceutiques contenant de la lamivudine, de la stavudine et de la nevirapine | |
| HUP0202888A2 (hu) | Xenogén oligo- és/vagy poliribonukleotidokat tartalmazó gyógyszerkészítmény | |
| CY1113562T1 (el) | Σκευασματα τομπραμυκινης για τη θεραπεια ενδοβρογχικων λοιμωξεων |